Prevalence of Osteoporosis in Sickle Cell Disease

CompletedOBSERVATIONAL
Enrollment

142

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

December 18, 2021

Study Completion Date

December 18, 2021

Conditions
Sickle Cell Disease
Interventions
OTHER

Questionnaire

For each subject recruited, will be collected for the study a questionnaire looking for a history of low energy fracture, and the origins of the patient (or relatives), as well as medical history, lifestyle (alcohol and tobacco consumption), weight and height. This data will be used for the secondary outcomes.

Trial Locations (1)

69437

Hôpital Edouard Herriot, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04299594 - Prevalence of Osteoporosis in Sickle Cell Disease | Biotech Hunter | Biotech Hunter